Laurion Capital Management LP Crispr Therapeutics Ag Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$33.68 - $62.53 $3.37 Million - $6.25 Million	-100,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$36.68 - $73.13 $3.67 Million - $7.31 Million	100,000 New	100,000 $6.09 Million
Q4 2018 Feb 14, 2019	SELL	$22.73 - $42.34 $3.93 Million - $7.31 Million	-172,725 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$44.35 - $65.71 $7.66 Million - $11.3 Million	172,725 New	172,725 $7.66 Million
Q4 2017 Feb 13, 2018	SELL	$16.95 - $23.48 $1.15 Million - $1.59 Million	-67,636 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$16.75 - $20.66 $1.13 Million - $1.4 Million	67,636	67,636 $1.21 Million

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.